RUNX1, another transcription factor mutated in breast cancer, was found as a key regulator of the ER+ luminal lineage whose disruption may contribute to the development of ER+ luminal breast cancer when under the background of either TP53 or RB1 loss (58). Here, RB1 is linked to breast cancer.